Microviable Therapeutics announces Research Collaboration with the University Medical Center Utrecht and Artizan Biosciences Inc.
Gijón, 21st July 2022, Microviable Therapeutics SL, a biotechnology company in preclinical stage developing novel microbiome-derived biotherapeutic products, announced a research agreement with the University Medical Center of Utrecht (The Netherlands) and Artizan Biosciences [...]
Microviable Therapeutics announces Research Collaboration with Venter Pharma and Inmunomet Intolerancia y Disbiosis
Gijón, July 7, 2022, Microviable Therapeutics SL, a biotechnology company in preclinical stage developing novel microbiome-derived biotherapeutic products, today announced that it has entered into a research contract with Venter Pharma SL. and Inmunomet [...]
Microviable Therapeutics welcomes Manuel Arenal on board
Microviable Therapeutics welcomes Manuel Arenal on board. He has Master´s degree in Business Administration and Management at the University of Oviedo (MBA, 2015). He holds Master in Management at the ESC Clermont-Ferrand (2016) although he [...]
Alejandro Lucia, researcher at the European University and collaborator of Microviable Therapeutics, National Award for Research in Sports Medicine.
It is always a pleasure to work with prestigious researchers. Congratulations Alejandro Lucia! for the award received. A group of ten researchers from various institutions, including Alejandro Lucia, a researcher at the European University and [...]
Microviable announces 1.5 million € investment to advance the company´s microbiota-derived biotherapeutic products.
Microviable Therapeutics SL, a preclinical stage biotechnology company developing orally administered biological drugs based on microbiota-derived products, announced 1.5 million euros seed funding from the private medical group Inmunomet Intolerancia y Disbiosis SL. Microviable [...]
Microviable will be attending Pharmabiotics Event 2022
Our CEO Claudio Hidalgo will be attending the Pharmabiotics Event 2022 taking place on April 20th-21st at Lyon. The Pharmabiotics Conference brings together players from academia and industry and it is an incredible opportunity to [...]
Microviable Therapeutics is hiring!
As part of our growth and consolidation as a microbiome company focused on therapeutics we have several openings to join our team! Are you ready to rock? Check out our careers section and submit [...]
Microviable Therapeutics to enter into a contractual agreement with BCD Bioscience.
Microviable Therapeutics SL (Gijón, Asturias, Spain), announced a contractual agreement with BCD Bioscience Inc. (California, USA) to work on microbial fermentation and novel prebiotics to modulate the human gut microbiome. Microviable expertise on gut microbiome research [...]